Zelanna Goldberg

Company: Replicate Bioscience

Job title: Chief Medical Officer

Seminars:

Panel Discussion: Evaluating Different Combination Strategies to Develop More Effective Cancer Treatments for Curing the Patients in Need 2:30 pm

Which of the current state of the art immunotherapies are likely to combine well with neoantigen therapies? Beyond checkpoint inhibitors, what combinations seem the most promising? Are there certain combinations which work better for different stages of cancer? Discussing combining neoantigen therapies with PD-L1 therapies, chemotherapies and immunoglobins.Read more

day: Day Two

Multitargeted Self-Replicating RNA for Off-The-Shelf Cancer Precision Immunotherapeutics 4:30 pm

Replicate Bioscience’s self-replicating RNA platform supports a unique and powerful approach to preventing and reversing the emergence of common acquired resistance mutations Using multigenic self-replicating RNA we have created precision immunotherapeutics that can be dosed in combination with SOC approved cancer agents, thus maintaining selective pressure on the tumour Mechanistically, the combination of the Replicate…Read more

day: Day Two